# Dexamethasone Sodium Phosphate Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current - FDA package records: 19 - Latest FDA row update: 08/20/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Eugia US LLC — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25) — FDA availability: Available — updated: 08/06/2026 - Fresenius Kabi USA, LLC — Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10) — FDA availability: Limited Availability — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10) — FDA availability: Limited Availability — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10) — FDA availability: Available — updated: 08/04/2026 - Hikma Pharmaceuticals USA, Inc. — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25) — FDA availability: Available — updated: 08/13/2026 - Mylan Institutional, a Viatris Company — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10) — FDA availability: Available — updated: 08/20/2026 - Mylan Institutional, a Viatris Company — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30) — FDA availability: Available — updated: 08/20/2026 - Mylan Institutional, a Viatris Company — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54) — FDA availability: Available — updated: 08/20/2026 - Mylan Institutional, a Viatris Company — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12) — FDA availability: Available — updated: 08/20/2026 - Somerset Therapeutics, LLC — Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25) — FDA availability: Available — updated: 07/20/2026 - Somerset Therapeutics, LLC — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10) — FDA availability: Available — updated: 07/20/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/dexamethasone-sodium-phosphate-injection) - [JSON record](https://citefacts.com/shortages/dexamethasone-sodium-phosphate-injection.json)